 Information about the risk was added to the Warnings and Precautions section of the Sprycel drug label.Dasatinib is an ATP-competitive protein tyrosine kinase inhibitor.The main targets of dasatinib are BCR/Abl (the "Philadelphia chromosome"), Src, c-Kit, ephrin receptors, and several other tyrosine kinases.